137 related articles for article (PubMed ID: 119893)
1. [Drug-induced hepatitis caused by unstable metabolites].
Pessayre D; Benhamou JP
Lille Med; 1979 Oct; 24(8):613-9. PubMed ID: 119893
[No Abstract] [Full Text] [Related]
2. [Drug-induced hepatits: the role of unstable metabolites (author's transl)].
Pessayre D; Benhamou JP
Acta Gastroenterol Belg; 1978; 41(9-10):574-86. PubMed ID: 735686
[No Abstract] [Full Text] [Related]
3. [Reactive metabolites of xenobiotics : their role in the hepatotoxicity of drugs].
Pessayre D; Benhamou JP
C R Seances Soc Biol Fil; 1979; 173(2):458-68. PubMed ID: 159767
[TBL] [Abstract][Full Text] [Related]
4. Drug metabolism as a cause of drug toxicity.
Mitchell JR; Jollow DJ; Gillette JR; Brodie BB
Drug Metab Dispos; 1973; 1(1):418-23. PubMed ID: 4149413
[No Abstract] [Full Text] [Related]
5. Editorial: Promising approaches to identify DILI drugs.
Li AP; Zhang J
Chem Biol Interact; 2016 Aug; 255():1-2. PubMed ID: 27393768
[No Abstract] [Full Text] [Related]
6. [Recent findings on the hepatotoxicity of drugs].
Altomare E; Vendemiale G; Stufano N; Di Monte D; Procacci V; Albano O
Recenti Prog Med; 1985 Nov; 76(11):598-605. PubMed ID: 3912875
[No Abstract] [Full Text] [Related]
7. Drugs in liver disease.
Branch RA
Clin Pharmacol Ther; 1998 Oct; 64(4):462-5. PubMed ID: 9797803
[No Abstract] [Full Text] [Related]
8. Hepatic injury and drug metabolism in patients with alpha-methyldopa-induced liver damage.
Sotaniemi EA; Hokkanen OT; Ahokas JT; Pelkonen RO; Ahlqvist J
Eur J Clin Pharmacol; 1977 Dec; 12(6):429-35. PubMed ID: 598417
[No Abstract] [Full Text] [Related]
9. Interactions of drug metabolites with hepatic cytochrome P-450. Some implications for drug metabolism.
Bast A
Pharm Weekbl Sci; 1982 Aug; 4(4):113-4. PubMed ID: 7133961
[No Abstract] [Full Text] [Related]
10. [Drug-induced liver lesions].
Teschke R
Dtsch Med Wochenschr; 1983 Feb; 108(5):190-4. PubMed ID: 6402354
[No Abstract] [Full Text] [Related]
11. Oxidation of alpha-methyldopa and other catechols by cytochrome P-450-generated superoxide anion: possible mechanism of methyldopa hepatitis.
Dybing E; Nelson SD; Mitchell JR; Sasame HA; Gillette JR
Mol Pharmacol; 1976 Nov; 12(6):911-20. PubMed ID: 187927
[No Abstract] [Full Text] [Related]
12. Enzyme induction.
Dollery CT
Br J Anaesth; 1972 Sep; 44(9):961-6. PubMed ID: 4564266
[No Abstract] [Full Text] [Related]
13. Uremia and the liver. II. Drugs and the liver in the uremic patient.
Simon P; Meyrier A; Brissot P
Nephron; 1981; 29(1-2):7-13. PubMed ID: 7035980
[No Abstract] [Full Text] [Related]
14. Drug-induced liver injury.
van Berge Henegouwen GP; Vogten AJ
Neth J Med; 1980; 23(1):23-32. PubMed ID: 6988728
[No Abstract] [Full Text] [Related]
15. Drug metabolism in the production of liver injury.
Mitchell JR; Potter WZ
Med Clin North Am; 1975 Jul; 59(4):877-85. PubMed ID: 238084
[No Abstract] [Full Text] [Related]
16. Overview of alkylation and peroxidation mechanisms in acute lethal hepatocellular injury by chemically reactive metabolites.
Mitchell JR; Smith CV; Hughes H; Lauterburg BH; Horning MG
Semin Liver Dis; 1981 May; 1(2):143-50. PubMed ID: 7347018
[No Abstract] [Full Text] [Related]
17. Ethanol--a hepatotoxic drug.
Lieber CS; Rubin E
Gastroenterology; 1968 Apr; 54(4):642-6. PubMed ID: 5652513
[No Abstract] [Full Text] [Related]
18. [Possibilities of liver damage by foreign substances].
Bien E
Pharmazie; 1985 Nov; 40(11):815-20. PubMed ID: 3938023
[No Abstract] [Full Text] [Related]
19. Interferon and drug metabolism.
Clin Pharm; 1983; 2(3):210-1. PubMed ID: 6192966
[No Abstract] [Full Text] [Related]
20. [Dangerous drugs in hepatic insufficiency].
Isal JP; Caulin C
Med Chir Dig; 1979; 8(5):447-9. PubMed ID: 534025
[No Abstract] [Full Text] [Related]
[Next] [New Search]
